Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$2.37M Sell
17,525
-111
-0.6% -$14.8K 0.61% 39
2024
Q2
$2.39M Sell
17,636
-677
-4% -$92.1K 0.66% 34
2024
Q1
$2.37M Sell
18,313
-5
-0% -$604 0.69% 34
2023
Q4
$2.09M Sell
18,318
-2,457
-12% -$245K 0.66% 37
2023
Q3
$1.89M Sell
20,775
-563
-3% -$58.1K 0.68% 37
2023
Q2
$2.4M Sell
21,338
-972
-4% -$103K 0.83% 31
2023
Q1
$2.34M Sell
22,310
-732
-3% -$76.4K 0.88% 29
2022
Q4
$2.55M Buy
+23,042
New +$2.42M 1.05% 27

Other funds holding XYL

CIC Wealth's XYL Position: Q3 2024 in Review

CIC Wealth reduced its Xylem (XYL) stake by 0.63% in Q3 2024, selling an estimated $14.8K and leaving 17,525 shares worth $2.37M. The position accounts for 0.61% of the portfolio, ranked #39.

CIC Wealth first reported a position in XYL in Q4 2022 and has held it in 8 quarters since. The position peaked at $2.55M in Q4 2022. 1,018 funds tracked by Wall St. Rank hold XYL as of Q3 2024.

  • CIC Wealth held 17,525 shares of Xylem worth $2.37M as of Q3 2024.
  • CIC Wealth sold 111 Xylem shares in Q3 2024, an estimated $14.8K.
  • Xylem made up 0.61% of CIC Wealth's portfolio in Q3 2024, its #39 holding.
  • CIC Wealth first reported a position in Xylem in Q4 2022 and has held it in 8 quarters since.
  • CIC Wealth's Xylem position peaked at $2.55M in Q4 2022.
  • 1,018 funds tracked by Wall St. Rank held Xylem as of Q3 2024.

Based on CIC Wealth's 13F filing for Q3 2024, filed 8 Nov 2024.